Alfateq

Alfateq was a specialist drug delivery company based in the United Kingdom, focused on enhancing the bioavailability and solubility of poorly water-soluble therapeutic agents. The company developed a proprietary platform known as Advanced Liquid Formulation Technology (AlfaTeQ), which utilizes lipid-based micro-emulsion systems for oral and transmucosal drug delivery. In 2003, Alfateq was acquired by Vectura Group to integrate its liquid formulation expertise into Vectura's broader respiratory and neurology pipelines. The AlfaTeQ technology has since been utilized to improve the pharmacokinetic profiles and onset of action for various drugs, particularly in the fields of pain management and respiratory health.